Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CMBS vs CEMB: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CMBS Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

CMBS Overall Winner 6-Pillar Tally: CMBS 0 – 0 CEMB (6 Tie) Matrix Metrics: CMBS 2 – 1 CEMB

As of Nov 16, 2026, iShares CMBS ETF (CMBS) is the stronger overall head-to-head candidate over iShares J.P. Morgan EM Corporate Bond ETF (CEMB) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CMBS carries a Unified Composite Score of 48.9/100 (HOLD) at $47.33 (N/M Forward P/E, N/A operating margin), whereas CEMB carries 41.5/100 (SELL) at $43.70 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: CMBS is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 38.6); meanwhile CEMB is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 32.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CMBS vs CEMB
CMBS NYSE Arca Head-to-Head Winner
iShares CMBS ETF
Institutional Equity
$47.33
-0.12% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.04β · 4% Vol
Unified Composite Score
48.9 / 100 HOLD
Tech 59.0 Fund 48.0 Flow 50.0 Mom 42.2
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.6%) with fading momentum, RSI 39
RSI-14: 38.6 · SMA20: $47.62 · SMA50: $47.55
CEMB Cboe BZX
iShares J.P. Morgan EM Corporate Bond ETF
Institutional Equity
$43.70
-0.18% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.15β · 3% Vol
Unified Composite Score
41.5 / 100 SELL
Tech 32.0 Fund 52.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -1.2%) with fading momentum, RSI 33
RSI-14: 32.5 · SMA20: $43.97 · SMA50: $44.16

6-Pillar Scorecard Institutional Category Breakdown (CMBS 0 – 0 CEMB)

Columns: Metric · CMBS · CEMB
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Distribution
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CMBS (2) vs CEMB (1)
Institutional Metric CMBS CEMB Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
9% ($47–$50) 3% ($44–$46) Stronger Trend CMBS
Beta / 30D Volatility
Risk Regime
0.04β · 4% Vol 0.15β · 3% Vol Lower Realized Risk CEMB
Unified Institutional Score
Composite Signal
48.9 / 100 (HOLD) 41.5 / 100 (SELL) Higher Composite CMBS
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CMBS +0.35 pp
CMBS: -0.55% · CEMB: -0.9%
3M Horizon CMBS +1.32 pp
CMBS: -2.15% · CEMB: -3.47%
6M Horizon CMBS +1.46 pp
CMBS: -2.31% · CEMB: -3.77%
1Y Horizon CMBS +1.41 pp
CMBS: -3.53% · CEMB: -4.94%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CMBS vs CEMB. Trailing 12-month operating profitability (CMBS N/A vs CEMB N/A) and valuation multiples (CMBS N/M vs CEMB N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CMBS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
CEMB ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CMBS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CMBS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CEMB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CEMB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CMBS Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
CEMB Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CMBS vs CEMB Key Questions & Quantitative Answers

As of Nov 16, 2026, iShares CMBS ETF (CMBS) is the stronger overall head-to-head candidate over iShares J.P. Morgan EM Corporate Bond ETF (CEMB) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CMBS carries a Unified Composite Score of 48.9/100 (HOLD) at $47.33 (N/M Forward P/E, N/A operating margin), whereas CEMB carries 41.5/100 (SELL) at $43.70 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: CMBS is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 38.6); meanwhile CEMB is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 32.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CMBS and CEMB split Growth & Scale metrics: CMBS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with CEMB at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CMBS generates N/A in USD-normalized revenue versus N/A for CEMB. In operating R&D and SG&A reinvestment, CMBS deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CEMB.

CMBS and CEMB trade at balanced relative valuation multiples. CMBS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas CEMB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CMBS (N/A ROE) versus CEMB (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, CMBS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.04β · 4% Vol realized risk). By comparison, CEMB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.15β · 3% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.